Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Crispr Therapeutics AG (1CG) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:1CGCrispr Therapeutics AGCHF 39.80CHF 3.71B-9.03-11.66%Moderate BuyUnlock the CH:1CG analyst price target with TipRanks PremiumCH:1CGUnlock the CH:1CG top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$10.55$1.60B-3.1711.17%HoldUnlock the NTLA analyst price target with TipRanks PremiumCH:1CG vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
BEAMBeam Therapeutics$24.03$2.67B-24.279.88%Strong BuyUnlock the BEAM analyst price target with TipRanks PremiumCH:1CG vs BEAMUnlock the BEAM top-analyst price target with TipRanks Premium
LEGNLegend Biotech$18.54$3.79B-1861.95-40.53%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumCH:1CG vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$127.17$11.51B-35.23100.17%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumCH:1CG vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:1CGCrispr Therapeutics AG39.80-5.25-11.66%
NTLAIntellia Therapeutics10.551.8821.68%
BEAMBeam Therapeutics24.032.3710.94%
LEGNLegend Biotech18.54-12.47-40.21%
KYMRKymera Therapeutics127.1763.5499.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts